Subsequently, we analysed the expression levels of these genes across 33 types of cancer and found that AXL, MERTK, TYRO3, CD24, HAVCR2 and CD47 exhibited higher expression levels, while TIMD4 and HAVCR1 showed relatively lower expression (Figure 1B). This evidence concerns the gene MERTK and cancer.